Repligen | RGEN - Koszty Sprzedaży

Cena Akcji
113.88
Dzienna Zmiana
-3.73 -3.17%
Miesięcznie
-15.89%
Rocznie
-18.67%
Q1 Prognozy TE
110.75




Koszty Sprzedaży Zmiana Data
Agilent USD 852M 19M 2025-12
Align Technology USD 363.97M 7.48M 2025-12
Bio Techne USD 104.6M 6.16M 2025-12
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Bruker USD 528M 46.9M 2025-12
Charles River Laboratories USD 722.27M 28.81M 2025-12
Danaher USD 2.87B 342M 2025-12
Dentsply International USD 518M 55M 2025-12
Exact Sciences USD 266.81M 18.18M 2025-09
General Electric Aerospace USD 8.92B 654M 2025-12
Henry Schein USD 2.44B 62M 2025-12
Illumina USD 400M 49M 2025-12
IQVIA Holdings USD 3.24B 518M 2025-12
Mettler Toledo International USD 473.97M 33.71M 2025-12
Myriad Genetics USD 63M 1.1M 2025-12
OraSure Technologies USD 15.43M 113K 2025-12
Pacific Biosciences Of California USD 28.9M 10M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Repligen USD 94.08M 5.79M 2025-12
Revvity USD 350.4M 26.05M 2025-12
Standard Biotools USD 12.41M 2.34M 2025-12
Thermo Fisher Scientific USD 7.58B 674M 2025-12
Waters USD 374.94M 47.13M 2025-12
West Pharmaceutical Services USD 501.1M 9.2M 2025-12